Inactive Instrument

All News Pharmagest Interactive SA Swiss Exchange

Equities

End-of-day quote Swiss Exchange Other stock markets
- ^EUR	-

05-08	Equasens: sales down 5% in Q1	CF
04-02	Equasens : RNPG virtually stable in 2023	CF

Equasens: sales down 5% in Q1	05-08	CF
Equasens: Q1 2024 revenue	05-07	GL
Equasens : RNPG virtually stable in 2023	04-02	CF
Equasens: 2023 Annual Results	03-29	GL
Equasens Société Anonyme Provides Revenue Guidance for the 2025	03-29	CI
Equasens Société anonyme Proposes Gross Dividend	03-29	CI
Equasens: annual sales growth of almost 3%	02-07	CF
Equasens: 2023 revenue: €219.7m, +2.6%	02-06	GL
Equasens Société Anonyme Reports Consolidated Revenue Results for the Fourth Quarter and Full Year of 2023	02-06	CI
Global markets live: Airbus, Tesla, HSBC, KKR, Pfizer...	01-03
Equasens to Acquire 70% Stake in Digipharmacie	01-03	MT
Equasens: acquires 70% stake in Digipharmacie	01-02	CF
Equasens: Acquisition of a majority stake in DIGIPHARMACIE	01-02	GL
Equasens Société anonyme acquired 70% stake in Digipharmacie.	01-01	CI
Equasens: changes to the management committee	12-27	CF
Equasens Group Announces Management Appointments, Effective 1 January 2024	12-27	CI
Equasens: Changes in the Equasens Group Executive Committee	12-27	GL
CAC40: up slightly, stalls at the 7300 pts mark	11-24	CF
Equasens: share price up, broker confirms its recommendation	11-24	CF
EQUASENS : Stifel maintains its recommendation on the share	11-24	CF

No results for this search